Drug reviews: asthma inhaler advair linked to rise in mortality from symptoms of asthma Advair, combining salmeterol (Serevent) and fluticasone (Flovent) is one of the best selling drugs in the world
buy coreg online without a prescription. Salmeterol is often a bronchodilator which dilates the airways and fluticasone is a steroid which reduces airway inflammation. However, the drug is here under scrutiny as a result of recent report that Advair may possibly increase asthma deaths. Producer GlaxoSmithKline, however, has rejected the findings and calls this content extremely irresponsible and riddled with inaccuracies.
Forbes magazine been in a short article on 6th April, reported that "growing evidence suggests that a small % of patients--perhaps 4,000 people 12 months, by one doctor's estimate--may be dying due to Advair or its Serevent component".
It quotes Dr. Shelley Salpeter, a clinical professor of medicine at Stanford University who argues who says both Advair and Serevent should be recalled. Dr. Shelley reviewed the final results of 19 previous trials of Serevent-style drugs and located that patients have twice the rate of asthma hospitalizations, twice the speed of life-threatening asthma and four times as many deaths as patients whorrrre not on those drugs.
Apparently, Advair and Serevent cause four of each and every five asthma-related deaths each year. "These drugs make asthma worse," Dr. Shelley says. By some estimates, asthma kills roughly 5,000 Americans annually. This extrapolates to 4000 asthma deaths associated with these drugs.
In response, Glaxo says its detractors are exaggerating the potential for loss. "The safety and efficacy of Advair can be extremely well-established with regulators and physicians around the globe," A Glaxo spokeswoman said. "The data we've are inconclusive," says Kathy A. Rickard, a Glaxo v . p . , echoing early responses by Wyeth about its Redux diet drug and Merck & Co. about its Vioxx painkiller.
Last month GlaxoSmithKline had reached an agreement using the U. S. regulator to update Advair's label with a brand new warning advising doctors to limit the application of the drug to patients that do not reap the benefits of other asthma drugs, or that are severe cases.
Current Mood:
nauseated